Clinical trials
Multiple Sclerosis trials in Hungary
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
61 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2004 | 1 |
| 2006 | 2 |
| 2007 | 3 |
| 2008 | 4 |
| 2009 | 5 |
| 2010 | 4 |
| 2011 | 2 |
| 2012 | 1 |
| 2013 | 7 |
| 2014 | 1 |
| 2015 | 2 |
| 2016 | 5 |
| 2017 | 5 |
| 2018 | 5 |
| 2019 | 1 |
| 2020 | 3 |
| 2021 | 3 |
| 2022 | 1 |
| 2023 | 2 |
| 2025 | 1 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 42 |
| Terminated | 11 |
| Active, not recruiting | 5 |
| Recruiting | 2 |
| Enrolling by invitation | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Biogen | 12 |
| Novartis Pharmaceuticals | 9 |
| Actelion | 5 |
| Bayer | 5 |
| Hoffmann-La Roche | 4 |
| Sanofi | 4 |
| Somogy Megyei Kaposi Mór Teaching Hospital | 4 |
| Celgene | 2 |
| GeNeuro SA | 2 |
| Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Multiple Sclerosis | 61 |
| Multiple Sclerosis, Relapsing-Remitting | 17 |
| Multiple Sclerosis, Chronic Progressive | 5 |
| Recurrence | 5 |
| Stroke | 3 |
| Brain Injuries, Traumatic | 1 |
| Cerebral Palsy | 1 |
| Demyelinating Diseases | 1 |
| Diffuse Cerebral Sclerosis of Schilder | 1 |
| Fatigue | 1 |
Trials
Showing 26 to 50 of 61. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.